MedTrace Logo

Non-invasive Mapping of Rhythm Disorders

NCT02647749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 492

Last updated 2026-05-14

No results posted yet for this study

Summary

This current care protocol follows the biomedical research protocol entitled "Non-invasive mapping of the heart ECG high amplification" that demonstrated the clinical value of noninvasive Cardioinsight® mapping system.

Guide the management of patients hospitalized for cardiac rhythm radiofrequency ablation of cardiac arrhythmias, implantation or programming of a pacemaker, or assess the risk of serious arrhythmias or sudden death, with the currently used non-invasive mapping routine. The results obtained with non-invasive mapping will be compared with those obtained with the conventional method without non-invasive mapping.

Conditions

  • Cardiac Rhythm Disorders

Interventions

DEVICE

Cardioinsight® mapping system

OTHER

Conventional method without non-invasive mapping

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Michel HAÏSSAGUERRE, Pr · University Hospital, Bordeaux

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-19
Primary Completion
2019-05-31
Completion
2020-05-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647749 on ClinicalTrials.gov